Mycobacterium Dx Research Lab is ranked among medical research organizations in Carlsbad, CA, with an America's Best Score of 60 out of 100, based on its 2025 Form 990.
To conduct scientific research on mycobacterium infections affecting humans and animals and to develop innovative technologies that enhance the diagnostic efficiency of tuberculosis in low-resource areas.
Main program · fiscal year 2025
During the tax year, the organization continued its project focused on screening Lipoarabinomannan LAM antibodies, which are diagnostic biomarkers of active tuberculosis. By identifying a pair of high-affinity LAM antibodies, the organization aims to significantly enhance the sensitivity and specificity of tuberculosis detection, potentially leading to improved diagnostic capabilities and better patient outcomes.$186,726 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 98¢ went to programs, 2¢ to management and 0¢ to fundraising.
Programs $186,726
Management $3,309
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Operating reserves (reduced: more than 3 years of cash)
47.8 mo; 47.8 mo in cash
21.5 / 25
Financial balance (median margin)
−73.8%
0 / 20
Transparency
4 full 990s, latest TY2025
20 / 20
Program growth
0.0% / yr
7.5 / 15
Track record
3 years
1.2 / 10
Debt load
0.0% of assets
10 / 10
Total
60.2 → 60
Spending on programs Not scored; America's Best needs 65%+
98%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$24,680Fiscal year 2025
Expenses$190,035Fiscal year 2025
Total assets$757,411Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$24,680
Expenses$190,035
Net income−$165,355
Net assets$757,411
Notable sources of revenue
Percent of total revenue
Contributions
$326
1.3%
Program services
$0
0.0%
Investment income
$24,354
98.7%
Other (net)
$0
0.0%
Assets / debt
Total assets
$757,411
Total liabilities
$0
Net assets
$757,411
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$41,238
Expenses$157,601
Net income−$116,363
Net assets$922,766
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$0
0.0%
Investment income
$41,238
100.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$922,766
Total liabilities
$0
Net assets
$922,766
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$40,834
Expenses$1,920
Net income$38,914
Net assets$1,039,129
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$0
0.0%
Investment income
$40,834
100.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,039,129
Total liabilities
$0
Net assets
$1,039,129
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$1,000,215
Expenses$0
Net income$1,000,215
Net assets$1,000,215
Notable sources of revenue
Percent of total revenue
Contributions
$1,000,000
100.0%
Program services
$0
0.0%
Investment income
$215
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,000,215
Total liabilities
$0
Net assets
$1,000,215
Compensation
Officers and key employees
$0
Share of expenses
—
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?